Codman Neurovascular

Codman Neurovascular markets a range of embolic devices including Trufill DCS Orbit Detachable Coil System, Trufill n-BCA Liquid Embolic System and variety of complementary access products including the Envoy Guiding Catheter, Prowler Select Microcatheters and the Hypertransit Microcatheter.

Codman also markets the Enterprise Self-Expanding Cerebral Stent System for use with endovascular coil embolization of wide-neck saccular intracranial artery aneurysms which recieved European CE Mark approval in December 2006 and an HDE (Humanitarian Device Exemption) from the FDA in May 2007.

Codman entered the neuroendovascular space in January 2009 when it announced that Cordis Neurovascular has become one of its strategic and was renamed to Codman Neurovascular.